Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pharmacia

This article was originally published in The Tan Sheet

Executive Summary

Rogaine third quarter U.S. sales reached $24 mil., a 25% decline, and $32 mil. worldwide, down 18% from the year-ago period, company reports Oct. 30. Pharmacia's marketing exclusivity for the hair regrowth formula expires Nov. 14; Perrigo recently postponed launch of its private label minoxidil 5% (1"The Tan Sheet" Oct. 30. p. 13). Revenue from U.S. sales of Nicorette reached $21 mil. in the quarter, up 5%, with flat worldwide sales of $50 mil. Pharmacia recently acquired the Nicotrol smoking cessation brand from McNeil (2"The Tan Sheet" Oct. 23, p. 6). Pharmacia net sales totaled $4.3 bil. in the quarter, up 15%, with net earnings up 61% to $427 mil

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS091863

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel